Search fresh public links, source activity, and ready-to-use post angles for Ai Biotech.
Fresh curated links around AI Biotech are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Black Book Research and Applied Artificial Intelligence LLC identify 2026-2027 client-rated technology leaders across 28 pharmaceutical, biotechnology and life sciences markets bas...
The founders of contract research organization Quartesian have reunited to form Acrosian, a CRO designed to be purpose-built for the AI era.
Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global pharmaceutical manufac...
A month after Chai Discovery tied up a major $400 million series C funding round, the AI drug discovery firm has teamed up with Bristol Myers Squibb.
This AI startup, which lists Nobel laureate David Baker among its co-founders, has announced a “world model” of a cell that can simulate both its natural state and […]
Insilico Medicine, an AI-based drug developer whose profile within biopharma has risen with its recent collaborations with industry giants, has offered investors an upbeat revenue...
Bristol Myers is the third pharmaceutical company to recently seek Nvidia’s help building a large AI data center. Elsewhere, a Novartis kidney drug gained a leg up on competitors.
Executed IP assignment brings a decade of technology, published research, and pharma-tested behavioral engagement capabilities into AimwellBio as the Company expands its scientific...
AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company advancing artificial intelligence and neural-network-based technologies for digital he...
The collaboration will enable the development, validation, and application of advanced AI technologies to identify clinically meaningful patient subgroups, support biomarker-driven...
Biogen's leading tau-targeting candidate has slowed cognitive decline across a suite of different clinical assessments, backing up the pharma’s decision to race the molecule into p...
A US-headquartered biotech firm plans to seek a primary listing in Hong Kong, joining a swelling pipeline of artificial intelligence-powered medical players raising capital in the...
Leveraging Advanced Diagnostics and Screenings to Provide Personalized Proactive Care
A new sourcing portal connects clinics with compounding pharmacies across peptides, GLP-1s, and other compounded therapeutics.
Ian reveals how AI is ehancing drug research, and why the first person to receive tomorrow’s newest medicine might not be human at all.
Biotech IPOs dominate the 2026 US market, overshadowing AI firms like Anthropic. Anthropic's IPO by December 31, 2026 at 63.5% YES. The post Biotech IPOs lead 2026 US market, overs...
Combines Insilico's Pharma.AI platform with Bora's global development, manufacturing, quality, and commercialization capabilities to explore a next-generation drug innovation model
New service combines advanced diagnostics, predictive health intelligence and world-class physician expertise to enable earlier detection and expert resolution
Bristol Myers Squibb has entered into an expanded collaboration with Nvidia to create the biggest supercomputer for drug R&D, according to the announcement.
Anthropic has just published the results of a protein design campaign. Fifteen targets, a written brief and an instruction to design small proteins that latch onto them. The model...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.